PHARMAGEN, INC. Depreciation and Amortization Expense
PHARMAGEN, INC. reported Depreciation and Amortization Expense of $30.15 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2014-05-15
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2014-03-31 was $30.15K, a 61.69% increase year-over-year.
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2013-12-31 was $28.65K, a 264.43% increase year-over-year.
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2013-09-30 was $26.73K, a 179.29% increase year-over-year.
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for the quarter ending 2013-06-30 was $20.35K, a 321.30% increase year-over-year.
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for fiscal 2013 was $94.38K, a 187.62% increase from fiscal 2012.
- PHARMAGEN, INC. depreciation, depletion and amortization, nonproduction for fiscal 2012 was $32.81K.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2014-03-31 | $30.15K 10-Q · filed 2014-05-15 | $58.80K derived: sum of 2 quarters · filed 2014-05-15 | $85.53K derived: sum of 3 quarters · filed 2014-05-15 | $105.88K derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-12-31 | $28.65K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $55.38K derived: sum of 2 quarters · filed 2014-03-31 | $75.73K derived: sum of 3 quarters · filed 2014-03-31 | $94.38K 10-K · filed 2014-03-31 |
| 2013-09-30 | $26.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $47.08K derived: sum of 2 quarters · filed 2013-11-14 | $65.73K 10-Q · filed 2013-11-14 | $73.59K derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-06-30 | $20.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $39.00K 10-Q · filed 2013-08-14 | $46.86K derived: sum of 3 quarters · filed 2014-05-15 | $56.43K derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-03-31 | $18.65K 10-Q · filed 2014-05-15 | $26.51K derived: sum of 2 quarters · filed 2014-05-15 | $36.08K derived: sum of 3 quarters · filed 2014-05-15 | $40.91K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $7.86K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $17.43K derived: sum of 2 quarters · filed 2014-03-31 | $22.26K derived: sum of 3 quarters · filed 2014-03-31 | $32.81K 10-K · filed 2014-03-31 |
| 2012-09-30 | $9.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $14.40K derived: sum of 2 quarters · filed 2013-11-14 | $24.95K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $4.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $15.38K 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | $10.55K 10-Q · filed 2013-05-15 |